Related Experiment Videos

Antibiotic susceptibility of Streptococcus pneumoniae isolated from clinical materials (author's transl)

Insights

Drug resistance in Streptococcus pneumoniae is increasing, particularly to tetracycline and chloramphenicol. Few strains showed macrolide resistance, with some exhibiting cross-resistance to other antibiotics.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Context:

  • Analysis of drug susceptibility patterns in Streptococcus pneumoniae strains.
  • Clinical isolates collected between January 1975 and May 1976.
  • Monitoring antimicrobial resistance trends in a key bacterial pathogen.

Purpose:

  • To assess the drug-susceptibility of Streptococcus pneumoniae isolates.
  • To identify emerging resistance patterns to common antibiotics.
  • To observe changes in the susceptibility profile of this pathogen over time.

Summary:

  • 112 Streptococcus pneumoniae strains showed consistent sensitivity to benzylpenicillin and cephaloridine.
  • High resistance rates were observed for tetracycline (59.8%) and chloramphenicol (44.7%).
  • Significant cross-resistance was noted between tetracycline and doxycycline, and chloramphenicol and thiamphenicol. Three strains displayed macrolide resistance, with varying cross-resistance profiles.

Impact:

  • Highlights the growing challenge of antibiotic resistance in Streptococcus pneumoniae.
  • Informs clinical decision-making regarding antibiotic selection for pneumococcal infections.
  • Provides baseline data for future surveillance of antimicrobial resistance trends.

Related Concept Videos